Insulin-like growth factor binding protein 2 promotes ovarian cancer cell invasion.

Abstract

We therefore showed that IGFBP2 enhances the invasion capacity of ovarian cancer cells. Blockage of IGFBP2 may thus constitute a viable strategy for targeted cancer therapy.